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Thymectomy of neonatal mice can result in the development of autoimmune pathology. 
It has been proposed that thymic output of regulatory T (T reg) cells is delayed during 
ontogeny and that the development of autoimmune disease in neonatally thymectomized 
mice is caused by the escape of self-reactive T cells before thymectomy without 
accompanying T reg cells. However, the kinetics of T reg cell production within the thymus 
during ontogeny has not been assessed. We demonstrate that the development of Foxp3-
expressing T reg cells is substantially delayed relative to nonregulatory thymocytes during 
ontogeny. Based on our data, we speculate that induction of Foxp3 in developing 
thymocytes and, thus, commitment to the T reg cell lineage is facilitated by a signal 
largely associated with the thymic medulla.
 
Appreciation of the existence of a dedicated
population of T reg cells can, in part, be traced
to early studies demonstrating that day 3 neonatal
thymectomy (NTx) of normal mice led to the
development of autoimmune pathology and
that this pathology could be prevented by
transfer of T cells from adult mice (for review
see reference 1). T reg cells are produced by
the adult thymus, and the provision of peripheral
CD25
 
 
 
CD4
 
 
 
 T reg cells from adult mice is
able to inhibit the development of autoimmunity
in NTx mice (2, 3). Thus, it has been proposed
that the thymic output of T reg cells is delayed
relative to nonregulatory T cells during ontogeny
and that development of autoimmune disease in
NTx mice results from a selective reduction in
T reg cells relative to self-reactive T cells exacer-
bated by NTx-induced lymphopenia (4). Con-
sistent with this hypothesis, an analysis of mice
during the first week after birth revealed that
the percentage of CD25
 
 
 
 cells among total
CD3
 
 
 
 splenocytes increased substantially be-
ginning at about postnatal day 4 (5). Day 3
NTx reduced the percentage of CD25
 
 
 
 T
cells and further delayed their appearance
in the spleen (5). However, the kinetics of
CD25
 
 
 
CD4
 
 
 
 single-positive (SP) development
within the thymus during ontogeny was not
assessed. Thus, the delay in appearance of
CD25
 
 
 
CD3
 
 
 
 cells in the spleen could result
from multiple factors not directly related to the
development of the T reg cell population in
the thymus.
The forkhead transcription factor, Foxp3,
plays a critical role in the development and
function of T reg cells (6–9). Foxp3 expression
in T cells specifies the T reg cell fate and, thus,
identifies T reg cells independently of expression
of any known cell surface marker (9). A recent
study addressing the development of T reg
cells during ontogeny demonstrates that Foxp3
mRNA expression can be detected in CD4
 
 
 
T cells from both the thymus and spleen of 3-d-
old  mice (10). In this report, an analysis of
adult mice after NTx revealed that although
the total number of CD4
 
 
 
 T cells was reduced,
the percentage of CD4
 
 
 
 cells expressing high
amounts of CD25 and the amount of total Foxp3
mRNA in this population was increased relative
to unthymectomized control mice. Based on
their observation that adult mice that were
thymectomized as neonates possess T reg cells
and in contrast to the hypothesis put forward
previously, these authors suggest that the pro-
duction of regulatory and nonregulatory CD4
 
 
 
T cells is not differentially regulated during
ontogeny. The reduced amounts of Foxp3
mRNA observed in thymic and spleen cells
from 3-d-old mice are ascribed to qualitative
differences in the signals driving T reg cell de-
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velopment in neonatal mice that result in lower amounts of
Foxp3 on a per cell basis. Thus, they propose that Foxp3-
expressing T reg cells develop in neonatal mice but that they
are less efficient suppressors.
Considering the major interest in understanding the sig-
nals that induce Foxp3 expression in developing thymocytes
and, thereby, drive thymic development of T reg cells, the
conflicting data regarding the development of T reg cells
during ontogeny, the absence of any direct analysis of T reg
cell development in the thymus during ontogeny, and our
observation that Foxp3 expression and not CD25 expression
directly correlates with the T reg cell lineage, we decided to
reexamine this issue. We now directly demonstrate that pro-
duction of Foxp3-expressing T reg cells is greatly delayed
relative to nonregulatory thymocytes during ontogeny.
 
RESULTS AND DISCUSSION
 
Using mice harboring a Foxp3 knock-in allele, 
 
Foxp3
 
gfp
 
, en-
coding a GFP–Foxp3 fusion protein (Foxp3
 
gfp
 
), we are able
to directly analyze Foxp3 expression at the single cell level
(9). To assess the thymic production of T reg cells during
ontogeny, we systematically analyzed neonatal 
 
Foxp3
 
gfp
 
 mice
during the first week after birth. Within 12 h after birth,
 
 
 
3.8% of CD4 SP thymocytes expressed high amounts of
CD25 (Fig. 1, A and B). The percentage of CD25
 
 
 
 CD4 SP
thymocytes increased over the next 2 d and reached a pla-
teau at 
 
 
 
5% by postnatal day 4. Thus, although the percent-
age of CD25-expressing CD4 SPs increased slightly during
the first days after birth, there was a substantial population of
CD25
 
 
 
 CD4 SPs present on postnatal day 1. Surprisingly,
 
 
 
0.1% of the CD4 SP cells expressed detectable Foxp3
 
gfp
 
within 12 h after birth (Fig. 1, A and B). The percentage of
Foxp3-expressing CD4 SP thymocytes increased slowly over
the following days and did not reach a plateau of 
 
 
 
4% until
 
 
 
21 d after birth. An analysis of Foxp3 expression by intra-
cellular staining of thymocytes from WT C57BL/6 mice
confirmed these results (unpublished data).
Restricting our analysis to the mature HSA
 
lo
 
CD4 SP
thymocyte population highlighted the progressive increase
in Foxp3-expressing T reg cells. The percentage of mature
HSA
 
lo
 
CD4 SPs expressing Foxp3
 
gfp
 
 was 
 
 
 
0.6% on postnatal
day 1 and increased 
 
 
 
16-fold to 
 
 
 
10% at day 21 (Fig. 1 C).
With the exception of postnatal day 1, there was no sub-
stantial difference in expression of Foxp3 on a per cell basis
as measured by mean fluorescence intensity within the
Foxp3
 
gfp
 
 
 
 gate (Fig. 1 A and not depicted). Interestingly, the
largest single-day change in the percentage of Foxp3-
expressing CD4 SPs occurred between days 3 and 4 for
HSA
 
lo
 
CD4 SPs (from 2.1 to 4.5%) and total CD4 SPs (from
0.7 to 1.9%; Fig. 1, B and C). Thus, Foxp3 induction in thy-
mocytes is regulated during ontogeny, and generation of
Foxp3-expressing T reg cells is delayed relative to generation
of nonregulatory CD4
 
 
 
 T cells.
Although very few Foxp3-expressing cells were evident
in the CD4 SP population at postnatal day 1, it is possible
that the Foxp3
 
gfp
 
 
 
CD25
 
 
 
CD4 SPs may express other cell
surface markers characteristic of the T reg cell population
that would identify them as precursors to the Foxp3
 
 
 
 CD4
SP population. We have previously phenotypically and
functionally characterized the four subpopulations of periph-
eral CD4
 
 
 
 T cells as defined by Foxp3 and CD25 expression
and found that both CD25
 
lo/neg
 
 and CD25
 
hi
 
 Foxp3-express-
ing cells possess suppressor activity, whereas the CD25
 
 
 
Foxp3
 
gfp
 
 
 
CD4
 
 
 
 T cell population is enriched for cells that
Figure 1. Appearance of Foxp3-expressing T reg cells is delayed 
during ontogeny. (A) Representative flow cytometric analysis of thymocytes 
from mice of the indicated age. Each column represents an individual mouse. 
The total live gate is shown in the CD4   CD8 plot in the first row. All other 
plots are gated on the CD4 SP population indicated in the first row. The 
numbers indicate the percentage of cells in each gate. (B) Mean percentage of 
CD25  or Foxp3gfp  cells among CD4 SPs. (C) Mean percentage of Foxp3gfp  
cells among HSAloCD4 SPs. Error bars represent the mean   SD. Data 
represent 5–7 mice analyzed per time point. Trend curves were derived using 
logarithmic least squares fitting of the mean values. 
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resemble recently activated or effector T cells and are hyper-
responsive to TCR stimulation (9). We examined the CD4
SP population in the thymus of adult mice. Although all four
subpopulations are evident, there were clear differences
when compared with peripheral CD4
 
 
 
 T cells (Fig. 2 and
Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20050784/DC1). Notably, the CD25
 
lo/neg
 
Foxp3
 
gfp
 
 
 
CD4 SP population in the adult thymus was consistently
smaller than the same population among lymph node CD4
 
 
 
cells and expressed lower amounts of Foxp3
 
gfp
 
 that clearly
increased as the amount of CD25 increased. In contrast,
many of the peripheral CD25
 
lo/neg
 
Foxp3
 
gfp
 
 
 
CD4
 
 
 
 T cells
expressing the lowest amounts of CD25 expressed high
amounts of Foxp3
 
gfp
 
 (Fig. S1). It is tempting to speculate that
in the thymus these are the cells that have just committed to
the T reg cell lineage and are simultaneously up-regulating
Foxp3 and CD25.
Next, we compared the Foxp3
 
gfp
 
 
 
CD25
 
 
 
CD4 SP popu-
lation from postnatal day 1 mice with the four subpopula-
tions of CD4 SPs as defined by Foxp3 and CD25 expression
from adult mice. By this comparison, cells from day 1 neo-
nates most closely resembled the CD25
 
 
 
CD4
 
 
 
Foxp3
 
gfp
 
 
 
population from adult mice. This population contained cells
with high amounts of CD69 and low amounts of both
CD62L and CTLA-4 and a broad distribution of OX-40 ex-
pression. Interestingly, GITR expression in the day 1 neo-
nate CD25
 
 
 
Foxp3
 
gfp
 
 
 
 CD4 SP population was substantially
lower than in each of the adult CD4 SP populations. Thus,
in addition to lacking Foxp3, the CD25
 
 
 
Foxp3
 
gfp
 
 
 
CD4 SP
thymocytes in postnatal day 1 mice expressed neither GITR
nor CTLA4 at amounts characteristic of T reg cells. It is
noteworthy that the CD25
 
 
 
 CD4 SP population was sub-
stantially larger during the first days after birth. As this popu-
lation has relatively higher expression of CD69 and lower
expression of CD62L, it is plausible that in newborn
mice  there is a selective increase in the proportion of
Foxp3
 
gfp
 
 
 
CD25
 
 
 
CD4 SPs that have recently undergone
positive selection. In addition, we speculate that this popula-
tion may be partially increased in neonatal mice because of
the presence of “would-be” T reg cells that, in the absence
of a signal required to induce Foxp3 expression, survive and
escape to the periphery as autoreactive T cells. Clearly these
possibilities are not mutually exclusive.
We have previously identified a small population of
HSA
 
hi
 
 Foxp3-expressing double-positive (DP) cells in the
adult thymus (9). One explanation for the paucity of Foxp3-
expressing T reg cells in the CD4 SP population in day 1 ne-
onates is that Foxp3-expressing T reg cell precursors transi-
tion through the thymocyte developmental pathway with
delayed kinetics relative to Foxp3
 
neg
 
 thymocytes. This hy-
pothesis would predict the presence of a distinct Foxp3-
expressing DP population before the appearance of Foxp3
 
 
 
SP thymocytes. To address this question we analyzed the dis-
tribution of all Foxp3-expressing cells among the thymocyte
subpopulations as defined by CD4 and CD8 expression. This
analysis revealed that even at postnatal day 1 
 
 
 
80% of Foxp3-
expressing cells were CD4 SPs. Thus, although the percent-
age of total Foxp3
 
gfp
 
 
 
 thymocytes increased steadily after
birth, no DP to SP developmental progression of Foxp3
 
gfp
 
 
 
thymocytes was observed (Fig. 3). Consistent with these re-
sults, we saw no difference in the percentage of SP and DP
Foxp3
 
gfp
 
 
 
 thymocytes expressing Ki67, a cell cycle–associated
nuclear protein (unpublished data). We have previously doc-
umented mature Foxp3
 
gfp
 
 
 
 MHC class II–restricted CD4 T
Figure 2. Phenotypic analysis of neonatal and adult CD4 SP 
thymocytes. (A) Representative flow cytometric analysis of CD25 and 
Foxp3gfp expression on CD4 SP thymocytes from a 6-wk-old mouse. The 
numbers indicate the percentage of cells in each gate. (B) Representative 
flow cytometric analysis of CD25 and Foxp3gfp expression on CD4 SP 
thymocytes from a 1-d-old mouse. The numbers indicate the percentage 
of cells in each gate. (C) Comparison of the indicated cell surface marker 
expression on postnatal day 1 CD25 Foxp3gfp  CD4 SPs with adult Foxp3/
CD25-expressing subpopulations. Closed colored histograms are shown 
for cells from each of the adult Foxp3   CD25 subpopulations and corre-
spond to the gated population of the same color and position in the plot 
in A (blue, CD25lo/negFoxp3gfp ; green, CD25hiFoxp3gfp ; red, CD25 Foxp3gfp ; 
gray, CD25 Foxp3gfp ). In every case, the open histogram overlay (black) 
shows the corresponding marker expression by the postnatal day 1 
CD25 Foxp3gfp  CD4 SP population as defined by the bottom right 
gate in B. 
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cells, Foxp3
 
gfp
 
 
 
 MHC class I–restricted CD8 T cells, and
Foxp3
 
gfp
 
 
 
CD4
 
 
 
CD8
 
 
 
 DP mature T cells in the periphery
(9). On their maturation, the thymic Foxp3
 
gfp
 
 
 
 DP popula-
tion could contribute to each of these populations. However,
the lack of a substantial population of cycling Foxp3
 
gfp
 
 
 
 SP
thymocytes argues against a scenario in which the Foxp3
 
gfp
 
 
 
DP thymocytes are precursors to all Foxp3
 
gfp
 
 
 
 SP thy-
mocytes, as this scenario would predict a proliferative burst to
account for the numerical increase in Foxp3
 
gfp
 
 
 
 SP cells.
More importantly, the observed delay in thymic production
of Foxp3-expressing T reg cells is not the result of a delayed
transition of Foxp3-expressing cells through the DP stage.
Furthermore, these data suggest that Foxp3 induction can oc-
cur at the DP stage but occurs preferentially at the CD4 SP
stage or during the transition to this stage.
Thymocyte development is a highly coordinated process
that requires molecular interactions between developing thy-
mocytes and the thymic epithelium (11). Alterations in the
biology of the thymic epithelium can have profound effects
on thymocyte development. Our recent work localized the
majority of Foxp3-expressing thymocytes to the medullary
region of the adult thymus (9). Thus, we speculated that de-
velopment of Foxp3-expressing thymocytes in the neonatal
mice may be limited by the medullary compartment. We ex-
amined localization of Foxp3-expressing cells and the relative
size of the medullary epithelial compartment in thymi of
newborn mice by immunohistochemistry at several time
points after birth. As previously reported for 6-wk-old mice
(9), Foxp3-expressing thymocytes were clearly evident and
largely localized to the thymic medulla of 3-wk-old mice.
The few Foxp3
 
gfp
 
 
 
 cells within the thymic cortex were in
proximity to the cortico-medullary junction. At 3 wk of age
the medullary compartments of these thymi, as revealed by
epithelial cellular adhesion molecule (Ep-CAM) staining,
were large and well defined (Fig. 4 A). In contrast, and con-
sistent with the data obtained by flow cytometry, there were
very few Foxp3-expressing T reg cells present in the thymi of
1-d-old mice (Fig. 4 A). This difference is compounded
when one considers that the absolute number of thymocytes
in a day 21 thymus is 
 
 
 
15-fold higher than in a day 1 thymus
(
 
 
 
200 
 
  106 vs.  15   106 cells). Interestingly, when com-
pared with the 3-wk thymi, the medullary regions of the day
1 thymi were much smaller relative to cortical areas and were
more disorganized. Examination of day 1, 4, and 9 and 3 wk
thymi revealed a progressive increase in the size and organiza-
tion of the Ep-CAM–positive medullary compartment rela-
tive to the thymic cortex (Fig. 4, A–C). At day 1 we ob-
served few small-sized medullary “islands” per section of
thymus, and these islands increased in number on day 4. At
day 9, medullary islands appeared to begin coalescing and in-
creasing in size, resulting in fewer but substantially larger is-
lands by 3 wk of age. These data correlated with the observed
increase in production of Foxp3-expressing T reg cells. Inter-
estingly, they also suggest the possibility of a less efficient
negative selection process during the neonatal period.
Given that Foxp3-expressing cells are almost exclusively
localized in the medulla, it is reasonable to speculate that a
qualitative and/or quantitative deficiency in this compart-
ment in newborn mice may contribute to the reduction in
Foxp3-expressing T reg cells in these mice. Consistent with
this hypothesis, mice with genetic deficiencies associated
with the disrupted architecture of the thymic medulla, in-
cluding NF- B–inducing kinase–deficient (Nikaly/aly) (12)
and TNF-associated receptor 6–deficient (Traf6 / ) (13)
mice show substantially reduced numbers of CD25 CD4 
thymocytes and lower relative levels of Foxp3 mRNA. Col-
lectively, these data suggest that the thymic medullary com-
partment may preferentially support the development of
Foxp3-expressing T reg cells. In apparent contradiction to
this notion, it has been reported that CD25 CD4  T reg
cells do develop in K14-A 
b mice in which expression of
MHC class II molecules is largely restricted to thymic corti-
cal epithelial cells (14). However, the percentage of CD25 
CD4 SP thymocytes in these mice was clearly decreased, and
this analysis was not restricted to the CD25hi population,
which contains the majority of Foxp3-expressing cells. Fur-
thermore, our results do not necessarily imply that the role
of the medulla is strictly limited to display of ligands for T
reg cell TCRs.
The efficient generation of T reg cells has recently been
demonstrated to require CD28 expression on thymocytes
(15). Interestingly, expression of B7-2 expression was largely
restricted to the thymic medulla (Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20050784/DC1). Al-
though we found no substantial difference in expression of
B7-2 between postnatal day 1, 4, and 9 thymi, B7-2 expres-
sion was increased in adult thymi (Fig. S2). Thus, limited
availability of CD28 ligands caused by a reduced and disorga-
nized thymic medulla may, at least in part, explain the delayed
production of Foxp3-expressing T reg cells during ontogeny.
Figure 3. Foxp3-expressing CD4 SPs appear coincidently with 
Foxp3-expressing DP thymocytes. Representative flow cytometric 
analysis of CD4 and CD8 expression on Foxp3gfp-expressing thymocytes 
from mice of the indicated age. Plots are gated on total live Foxp3gfp  
cells. The numbers indicate the percentage of cells in each gate.JEM VOL. 202, October 3, 2005 905
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Although our results are at odds with conclusions drawn in
a recent work by Dujardin et al. regarding the production of
Foxp3-expressing thymocytes in newborn mice, they are not
incompatible with their observation of high amounts of Foxp3
mRNA in adult NTx mice (10). Lymphopenia-induced ex-
pansion of small numbers of Foxp3-expressing cells or periph-
eral induction of Foxp3 in recent thymic emigrants present in
the periphery at the time of thymectomy on lymphopenia-
induced expansion could explain this observation.
Concluding remarks
The data presented here conclusively demonstrate that pro-
duction of Foxp3-expressing T reg cells by the thymus
is considerably delayed relative to nonregulatory SP thy-
mocytes during mouse ontogeny. Although the thymus is
producing mature CD4 SP thymocytes, it is not producing
Foxp3  mature CD4 SP thymocytes in the first days after
birth. Thus, there is an imbalance in the relative proportion
of these two populations in neonatal mice. The delayed ap-
pearance of Foxp3-expressing T reg cells during ontogeny
may also help to explain the previously reported enhanced
homeostatic proliferation of T cells in neonatal mice (16), as
Foxp3-expressing T reg cells are known to control this pro-
cess (17, 18). Moreover, the dearth of Foxp3-expressing T
reg cells is consistent with the breakdown of tolerance ob-
served in neonatal mice (19–21).
Our data argue that a unique niche supports the induc-
tion of Foxp3 expression and that this niche is not available
in neonatal mice. We propose that a factor, largely associated
with the medulla, is contributing to Foxp3 induction and,
therefore, limiting the size of the T reg cell population.
What is the source of this additional signal required for
Foxp3 induction? The possibilities include thymic epithelial
cells (in particular medullary thymic epithelium), perhaps an-
other hematopoietic cell type (in particular dendritic cells),
or perhaps mature thymocytes localized to the medulla.
What is the nature of this signal? As previously mentioned,
expression of CD28 ligands could contribute to this process.
Alternatively, another, as yet unknown, cell surface mole-
cule or a molecule heretofore not implicated in this process
could also play this role. This delay may also result from an
early deficiency in a particular cytokine.
In conclusion, these data provide experimental support
and a molecular mechanism (i.e., the lack of Foxp3 induction
in developing thymocytes) for the long-standing but recently
challenged hypothesis that production of T reg cells is delayed
during ontogeny and, thus, contributes to the development of
autoimmunity in neonatally thymectomized mice. Elucida-
tion of the processes that result in the delayed development of
Foxp3-expressing T reg cells in newborn mice should yield
new insight into the molecular mechanisms that generate this
critical T cell population.
Figure 4. Progressive increase in size and organization of thymic 
medulla during ontogeny. (A) Representative immunohistochemical 
analysis of thymic sections from mice of the indicated age. Foxp3gfp  thy-
mocytes (green,  GFP), thymic cortex (red, DEC-205), and thymic medulla 
(blue, Ep-CAM) are shown. Magnification   10. (B) Mean medulla/cortex 
ratio in thymic sections from 1-, 4-, 9-d-old and 3-wk-old mice. Every 
fourth or fifth serial section of thymi from mice of the indicated age 
(three or four individual mice per time point) was stained for Ep-CAM 
and randomly chosen for morphometric analysis. Error bars represent the 
mean   SD. (C) Mean medulla/cortex ratio, mean total medullary area 
(mm2), and mean number of medullary islands per section with standard 
deviations from the mean.REGULATION OF FOXP3 EXPRESSION DURING ONTOGENY | Fontenot et al. 906
MATERIALS AND METHODS
Mice. Mice were housed under specific pathogen-free conditions and used
according to the guidelines of the Institutional Animal Care Committee at the
University of Washington. The Foxp3gfp mice were maintained as a homozy-
gous line on a mixed C57BL/6   129 background and have been previously
described (9). Mice were analyzed at 6–8 wk or at the age specified. For anal-
ysis of newborn mice, heavily pregnant females were checked every 12–14 h,
and on discovery of new pups, the day 1 time point was marked. Analysis was
performed at this time point and/or at  24-h intervals afterward.
Antibodies and flow cytometric analysis. All antibodies (with the ex-
ception of anti-GITR [DTA-1]) were direct fluorochrome conjugates pur-
chased from BD Biosciences and eBioscience and were used as previously de-
scribed (7). FACS analysis was preformed using FACSCalibur and FACSCanto
instruments (Becton Dickinson) and analyzed using FlowJo software (Tree Star,
Inc.). Purified anti-GITR (provided by S. Sakaguchi, Kyoto University, Kyoto,
Japan) was biotinylated and detected using streptavidin–PE conjugate.
Microscopy and immunohistochemistry. Thymic sections were pre-
pared and stained as described previously (22) using rabbit anti-GFP anti-
body, digoxigenin-conjugated mAb G8-8 to detect Ep-CAM (Ly74), and
Alexa 647–conjugated NLDC-145 to detect DEC-205, followed by Alexa
546–conjugated goat anti–rabbit IgG and Alexa 488–conjugated antidigoxi-
genin. The B7-2 was detected using digoxigenin-conjugated mAb GL1 and
antidigoxigenin-fluorescein (Roche), followed by Alexa 488–conjugated
rabbit antifluorescein (Invitrogen).
For the analysis of thymic architecture during postnatal development,
serial thymic sections were prepared from 1-, 4-, and 9-d-old and 3-wk-old
mice. Every fourth or fifth section was stained with anti–Ep-CAM antibody
G8.8 as described above. The entire thymic cross section (11–17 sections
per time point) was subjected to morphometric analysis to evaluate the
overall size of the cortical and medullary areas and the total number and
mean size of medullary islands per thymic cross section.
Online supplemental material. Fig. S1 shows a flow cytometric analysis
of Foxp3gfp CD4 SP thymocytes or lymph node CD4  T cells using a
panel of cell surface markers. Fig. S2 shows immunohistochemical analysis
of thymic sections from mice of the indicated age for B7-2 expression using
mAb GL1. Online supplemental material is available at http://www.jem.org/
cgi/content/full/jem.20050784/DC1.
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